SIRCE II

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q00072

NAICS

541512 - Computer Systems Design Services

Classification Code

DA01

Additional Details
Set Aside

NONE

Place of Performance

Rockville, Maryland, UNITED STATES

SourceSAM
Documents4
The U.S. Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Sources Sought notice (Procurement Identifier: 75F40126Q00072) as part of its ongoing market research for the SIRCE II initiative—Systems for Inspection & Imports, Recalls Compliance, and Enforcement. This Request for Information (RFI) is intended to identify qualified vendors with the capability, capacity, and innovative approaches necessary to deliver comprehensive IT modernization and support services for the FDA’s Office of Information and Informatics (OII). The SIRCE II initiative is focused on enhancing and modernizing the FDA’s critical systems that support inspection, import oversight, recall management, compliance, and enforcement activities. The intended outcome is to ensure these systems are robust, secure, and capable of supporting the FDA’s mission to protect public health. The scope of the anticipated procurement encompasses a broad range of computer systems design services, as classified under NAICS code 541512 (Computer Systems Design Services, 2022 version), with a Product Service Code of DA01. Key requirements and objectives for this market research include assessing industry capabilities to provide end-to-end IT modernization, support, and potentially innovative solutions that align with the FDA’s operational needs. Respondents are expected to demonstrate their experience and capacity to deliver large-scale IT services, with the estimated contract ceiling recently amended to $300,000,000. The FDA is particularly interested in understanding the breadth of available solutions, industry best practices, and the ability of vendors to support mission-critical systems. The place of performance for this initiative is Rockville, Maryland, USA. There are no set-aside requirements for this procurement; it is open to all qualified vendors regardless of business size or socioeconomic status. This notice is strictly for market research purposes and does not constitute a solicitation for proposals or bids. The contracting activity is managed by the FDA Office of Acquisition and Grant Services. Interested parties are encouraged to review the notice and its four attachments on SAM.gov for further details. The primary point of contact for this opportunity is Noah Padilla ([email protected]), with Steven Gagnon ([email protected]) listed as the secondary contact. Contractors considering this opportunity should note that the FDA is seeking comprehensive, innovative, and scalable IT solutions to support its regulatory and enforcement functions. The agency values demonstrated expertise in large-scale systems design and modernization, as well as the ability to support mission-critical federal IT environments over the contract lifecycle. The notice remains active, with a response deadline of March 6, 2026. Interested vendors should ensure their responses are thorough and address the FDA’s stated objectives and requirements as outlined in the RFI and its amendments. For more information and to access the full notice, visit: https://sam.gov/opp/20ac332b0c214c30a2a8268714ef27d9/view